Pfizer Inc
NYSE:PFE
Pfizer Inc
NYSE:PFE
Price:
28.88 USD
0.66%
Market Closed
Updated:
May 25, 2024
Pfizer Inc
Total Receivables
|
Pfizer Inc
Total Receivables Peer Comparison
Comparables:
JNJ
BMY
MRK
ZTS
LLY
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pfizer Inc
NYSE:PFE
|
Total Receivables
$15.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Receivables
$14.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Receivables
$14.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Receivables
$12.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Total Receivables
$1.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Receivables
$10B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
See Also
What is Pfizer Inc's Total Receivables?
Total Receivables
15.2B
USD
15.2B
USD
Based on the financial report for Mar 31, 2024, Pfizer Inc's Total Receivables amounts to 15.2B USD.
What is Pfizer Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
5%
5%
Over the last year, the Total Receivables growth was -1%. The average annual Total Receivables growth rates for Pfizer Inc have been 16% over the past three years , 10% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
